406 related articles for article (PubMed ID: 14580333)
1. Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism.
Castrillo A; Joseph SB; Vaidya SA; Haberland M; Fogelman AM; Cheng G; Tontonoz P
Mol Cell; 2003 Oct; 12(4):805-16. PubMed ID: 14580333
[TBL] [Abstract][Full Text] [Related]
2. Do macrophage innate immune receptors enhance atherogenesis?
Gordon S
Dev Cell; 2003 Nov; 5(5):666-8. PubMed ID: 14602065
[TBL] [Abstract][Full Text] [Related]
3. An LXR-NCOA5 gene regulatory complex directs inflammatory crosstalk-dependent repression of macrophage cholesterol efflux.
Gillespie MA; Gold ES; Ramsey SA; Podolsky I; Aderem A; Ranish JA
EMBO J; 2015 May; 34(9):1244-58. PubMed ID: 25755249
[TBL] [Abstract][Full Text] [Related]
4. Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence.
Stack J; Haga IR; Schröder M; Bartlett NW; Maloney G; Reading PC; Fitzgerald KA; Smith GL; Bowie AG
J Exp Med; 2005 Mar; 201(6):1007-18. PubMed ID: 15767367
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of liver x receptor/retinoid X receptor-mediated transcription contributes to the proatherogenic effects of arsenic in macrophages in vitro.
Padovani AM; Molina MF; Mann KK
Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1228-36. PubMed ID: 20339114
[TBL] [Abstract][Full Text] [Related]
6. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis.
Chawla A; Boisvert WA; Lee CH; Laffitte BA; Barak Y; Joseph SB; Liao D; Nagy L; Edwards PA; Curtiss LK; Evans RM; Tontonoz P
Mol Cell; 2001 Jan; 7(1):161-71. PubMed ID: 11172721
[TBL] [Abstract][Full Text] [Related]
7. SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR.
Wong J; Quinn CM; Brown AJ
Biochem J; 2006 Dec; 400(3):485-91. PubMed ID: 16901265
[TBL] [Abstract][Full Text] [Related]
8. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway.
Yamamoto M; Sato S; Hemmi H; Hoshino K; Kaisho T; Sanjo H; Takeuchi O; Sugiyama M; Okabe M; Takeda K; Akira S
Science; 2003 Aug; 301(5633):640-3. PubMed ID: 12855817
[TBL] [Abstract][Full Text] [Related]
9. Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression.
Wagner BL; Valledor AF; Shao G; Daige CL; Bischoff ED; Petrowski M; Jepsen K; Baek SH; Heyman RA; Rosenfeld MG; Schulman IG; Glass CK
Mol Cell Biol; 2003 Aug; 23(16):5780-9. PubMed ID: 12897148
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 3 mediates a more potent antiviral response than Toll-like receptor 4.
Doyle SE; O'Connell R; Vaidya SA; Chow EK; Yee K; Cheng G
J Immunol; 2003 Apr; 170(7):3565-71. PubMed ID: 12646618
[TBL] [Abstract][Full Text] [Related]
11. DNA topoisomerase II inhibitors induce macrophage ABCA1 expression and cholesterol efflux-an LXR-dependent mechanism.
Zhang L; Jiang M; Shui Y; Chen Y; Wang Q; Hu W; Ma X; Li X; Liu X; Cao X; Liu M; Duan Y; Han J
Biochim Biophys Acta; 2013 Jun; 1831(6):1134-45. PubMed ID: 23466610
[TBL] [Abstract][Full Text] [Related]
12. Autoregulation of the human liver X receptor alpha promoter.
Laffitte BA; Joseph SB; Walczak R; Pei L; Wilpitz DC; Collins JL; Tontonoz P
Mol Cell Biol; 2001 Nov; 21(22):7558-68. PubMed ID: 11604492
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid receptor regulates ATP-binding cassette transporter-A1 expression and apolipoprotein-mediated cholesterol efflux from macrophages.
Ayaori M; Sawada S; Yonemura A; Iwamoto N; Ogura M; Tanaka N; Nakaya K; Kusuhara M; Nakamura H; Ohsuzu F
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):163-8. PubMed ID: 16254209
[TBL] [Abstract][Full Text] [Related]
14. Effect of macrophage overexpression of murine liver X receptor-alpha (LXR-alpha) on atherosclerosis in LDL-receptor deficient mice.
Teupser D; Kretzschmar D; Tennert C; Burkhardt R; Wilfert W; Fengler D; Naumann R; Sippel AE; Thiery J
Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2009-15. PubMed ID: 18787185
[TBL] [Abstract][Full Text] [Related]
15. Statins inhibit synthesis of an oxysterol ligand for the liver x receptor in human macrophages with consequences for cholesterol flux.
Wong J; Quinn CM; Brown AJ
Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2365-71. PubMed ID: 15514210
[TBL] [Abstract][Full Text] [Related]
16. Pitavastatin effect on ATP binding cassette A1-mediated lipid efflux from macrophages: evidence for liver X receptor (LXR)-dependent and LXR-independent mechanisms of activation by cAMP.
Zanotti I; Potì F; Favari E; Steffensen KR; Gustafsson JA; Bernini F
J Pharmacol Exp Ther; 2006 Apr; 317(1):395-401. PubMed ID: 16415093
[TBL] [Abstract][Full Text] [Related]
17. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
[TBL] [Abstract][Full Text] [Related]
18. Gene-selective modulation by a synthetic oxysterol ligand of the liver X receptor.
Quinet EM; Savio DA; Halpern AR; Chen L; Miller CP; Nambi P
J Lipid Res; 2004 Oct; 45(10):1929-42. PubMed ID: 15292374
[TBL] [Abstract][Full Text] [Related]
19. Liver x receptor agonists inhibit cytokine-induced osteopontin expression in macrophages through interference with activator protein-1 signaling pathways.
Ogawa D; Stone JF; Takata Y; Blaschke F; Chu VH; Towler DA; Law RE; Hsueh WA; Bruemmer D
Circ Res; 2005 Apr; 96(7):e59-67. PubMed ID: 15790955
[TBL] [Abstract][Full Text] [Related]
20. Chlamydia pneumoniae-induced foam cell formation requires MyD88-dependent and -independent signaling and is reciprocally modulated by liver X receptor activation.
Chen S; Sorrentino R; Shimada K; Bulut Y; Doherty TM; Crother TR; Arditi M
J Immunol; 2008 Nov; 181(10):7186-93. PubMed ID: 18981140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
